Lifestyle and severe SARS-CoV-2 infections: Does the individual metabolic burden determines the outcome?

J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320963929. doi: 10.1177/1470320320963929.

Authors

Birgit Markus¹, Julian Kreutz¹, Bernhard Schieffer¹

Affiliation

¹ Department of Cardiology, Angiology and Intensive Care Medicine, Philipps University of Marburg, University Hospital (UKGM), Marburg, Germany.

No abstract available

Keywords: ACE2; SARS-CoV-2; diabetes; individual metabolic burden; lifestyle; obesity.

MeSH terms

Angiotensin-Converting Enzyme 2
Animals
Betacoronavirus*
COVID-19
Comorbidity
Coronavirus Infections / epidemiology*
Diabetes Mellitus / enzymology
Diabetes Mellitus / epidemiology
Diabetes Mellitus / virology
Humans
Hypertension / epidemiology
Hypertension / virology
Inflammation / epidemiology
Inflammation / virology
Insulin Resistance
Life Style*
Obesity / epidemiology
Obesity / virology
Pandemics
Peptidyl-Dipeptidase A / physiology
Pneumonia, Viral / epidemiology*
SARS-CoV-2
Severity of Illness Index
Treatment Outcome

Substances

Peptidyl-Dipeptidase A
ACE2 protein, human
Angiotensin-Converting Enzyme 2